Deliconstantinos G, Tsopanakis C, Karayiannakos P, Skalkeas G
Atherosclerosis. 1986 Jul;61(1):67-75. doi: 10.1016/0021-9150(86)90114-0.
Isolation of non-esterified [14C]cholesterol bound to albumin from rat serum, 8 days after i.p. injection of [14C]cholesterol, was achieved by affinity chromatography, using Cibacron blue F3GA bound to Sepharose 4B and by Sephadex G-150 column chromatography. Both methods permit isolation of large quantities of cholesterol-loaded albumin, free of globulins and lipoproteins. The isolated albumin-cholesterol fraction was estimated to be 4.6 mg/100 ml serum, which represents approx. the 24% of the non-esterified cholesterol present in the rat serum. Albumin-cholesterol, cholesterol glucoside, cholesterol hemisuccinate and hydroxylated derivatives of cholesterol produced a biphasic curve of changes in synaptosomal plasma membranes (SPM)-bound (Na+ + K+)-stimulated ATPase activity. Low concentrations of the ligand progressively increased the enzyme activity, while increasing the ligand concentration above that which maximally stimulated the enzyme activity, produced a progressive inhibition. Lipoproteins did not have any effect on the enzyme activity. The fluorescence anisotropy of 1,6-diphenyl-1,3,5-hexatriene-labeled SPM, increased in albumin-cholesterol derivatives-treated SPM, which is consistent with a general decrease in membrane bilayer fluidity. The results provide evidence that the 'albumin-cholesterol' fraction of the serum may directly affect the cell membrane-bound enzyme activity.
腹腔注射[14C]胆固醇8天后,通过亲和层析(使用偶联到琼脂糖凝胶4B上的汽巴蓝F3GA)和葡聚糖凝胶G - 150柱层析,从大鼠血清中分离出与白蛋白结合的非酯化[14C]胆固醇。两种方法都能分离出大量不含球蛋白和脂蛋白的载胆固醇白蛋白。分离出的白蛋白 - 胆固醇组分估计为4.6毫克/100毫升血清,约占大鼠血清中非酯化胆固醇的24%。白蛋白 - 胆固醇、胆固醇葡萄糖苷、胆固醇半琥珀酸酯和胆固醇的羟基化衍生物在突触体细胞膜(SPM)结合的(Na+ + K+)刺激的ATP酶活性变化中产生双相曲线。低浓度的配体逐渐增加酶活性,而当配体浓度增加到超过最大刺激酶活性的浓度时,则产生逐渐抑制。脂蛋白对酶活性没有任何影响。用白蛋白 - 胆固醇衍生物处理的SPM中,1,6 - 二苯基 - 1,3,5 - 己三烯标记的SPM的荧光偏振增加,这与膜双层流动性的普遍降低一致。结果提供了证据表明血清中的“白蛋白 - 胆固醇”组分可能直接影响细胞膜结合酶的活性。